Every medicine authorised for the Irish market — 10,165 products with active substances, licence holders, dosage forms and prescription status.
| Medicine | Active substance | Licence holder | Status |
|---|---|---|---|
| Puregon EU/1/96/008/017 |
Follitropin beta | N.V. Organon | — |
| Puregon EU/1/96/008/018 |
Follitropin beta | N.V. Organon | — |
| Puregon EU/1/96/008/019 |
Follitropin beta | N.V. Organon | — |
| Puregon EU/1/96/008/020 |
Follitropin beta | N.V. Organon | — |
| Puregon EU/1/96/008/021 |
Follitropin beta | N.V. Organon | — |
| Puregon EU/1/96/008/022 |
Follitropin beta | N.V. Organon | — |
| Puregon EU/1/96/008/023 |
Follitropin beta | N.V. Organon | — |
| Puregon EU/1/96/008/024 |
Follitropin beta | N.V. Organon | — |
| Puregon EU/1/96/008/025 |
Follitropin beta | N.V. Organon | — |
| Puregon EU/1/96/008/026 |
Follitropin beta | N.V. Organon | — |
| Puregon EU/1/96/008/027 |
Follitropin beta | N.V. Organon | — |
| Puregon EU/1/96/008/028 |
Follitropin beta | N.V. Organon | — |
| Puregon EU/1/96/008/029 |
Follitropin beta | N.V. Organon | — |
| Puregon EU/1/96/008/030 |
Follitropin beta | N.V. Organon | — |
| Puregon EU/1/96/008/031 |
Follitropin beta | N.V. Organon | — |
| Puregon EU/1/96/008/032 |
Follitropin beta | N.V. Organon | — |
| Puregon EU/1/96/008/033 |
Follitropin beta | N.V. Organon | — |
| Puregon EU/1/96/008/034 |
Follitropin beta | N.V. Organon | — |
| Puregon 150 IU/0.18 mL Solution for injection EU/1/96/008/040 |
Follitropin beta | N.V. Organon | — |
| Puregon 300 IU/0.36 mL Solution for injection EU/1/96/008/038 |
Follitropin beta | N.V. Organon | — |
| Puregon 600 IU/0.72 mL Solution for injection EU/1/96/008/039 |
Follitropin beta | N.V. Organon | — |
| Puregon 900 IU/1.08 mL Solution for injection EU/1/96/008/041 |
Follitropin beta | N.V. Organon | — |
| Pylclari 1000 MBq/mL solution for injection EU/1/23/1746/001 |
2-(3-{1-carboxy-5-[(6-[(18)F]fluoro-pyridine-3-carbonyl)-amino]-pentyl}-ureido)-pentanedioic acid | Curium Pet France | — |
| Pylobactell, 100 mg, Soluble Tablet EU/1/98/064/01 |
13c-urea | Richen Europe S.r.l. | — |
| Pyranistole 200 mg prolonged release capsules PA22865/001/001 |
Dipyridamole | Renata Pharmaceuticals (Ireland) Limited | Marketed |
| Pyrukynd EU/1/22/1662/004-005 |
Mitapivat Sulfate | Agios Netherlands B.V. | — |
| Pyrukynd 5 mg film-coated tablets EU/1/22/1662/001-003 |
Mitapivat Sulfate | Agios Netherlands B.V. | — |
| Pyrukynd 50 mg film-coated tablets EU/1/22/1662/006 |
Mitapivat Sulfate | Agios Netherlands B.V. | — |
| Pyzchiva 130 mg concentrate for solution for infusion EU/1/24/1801/003 |
Ustekinumab | Samsung Bioepis NL B.V. | — |
| Pyzchiva 45 mg solution for injection in pre-filled pen EU/1/24/1801/004 |
Ustekinumab | Samsung Bioepis NL B.V. | — |
| Pyzchiva 45 mg solution for injection in pre-filled syringe EU/1/24/1801/001 |
Ustekinumab | Samsung Bioepis NL B.V. | — |
| Pyzchiva 90 mg solution for injection in pre-filled pen EU/1/24/1801/005 |
Ustekinumab | Samsung Bioepis NL B.V. | — |
| Pyzchiva 90 mg solution for injection in pre-filled syringe EU/1/24/1801/002 |
Ustekinumab | Samsung Bioepis NL B.V. | — |
| Qaialdo 10 mg/ml oral suspension EU/1/23/1731/001 |
Spironolactone | Lipomed GmbH | — |
| Qalsody 100 mg solution for injection EU/1/23/1783/001 |
Tofersen | Biogen Netherlands B.V. | — |
| Qarziba 4.5 mg/mL concentrate for solution for infusion EU/1/17/1191/001 |
Dinutuximab beta | EUSA Pharma (Netherlands) B.V. | — |
| Qdenga powder and solvent for solution for injection EU/1/22/1699/001 |
Dengue virus, serotype 2, expressing Dengue virus, serotype 1, surface proteins, live, attenuated, Dengue virus, serotype 2, live, attenuated, Dengue virus, serotype 2, expressing Dengue virus, serotype 3, surface proteins, live, attenuated, Dengue virus, serotype 2, expressing Dengue virus, serotype 4, surface proteins, live, attenuated | Takeda Pharmaceuticals International AG Ireland Branch | — |
| Qdenga powder and solvent for solution for injection EU/1/22/1699/002 |
Dengue virus, serotype 2, expressing Dengue virus, serotype 1, surface proteins, live, attenuated, Dengue virus, serotype 2, live, attenuated, Dengue virus, serotype 2, expressing Dengue virus, serotype 3, surface proteins, live, attenuated, Dengue virus, serotype 2, expressing Dengue virus, serotype 4, surface proteins, live, attenuated | Takeda Pharmaceuticals International AG Ireland Branch | — |
| Qdenga powder and solvent for solution for injection EU/1/22/1699/003 |
Dengue virus, serotype 2, expressing Dengue virus, serotype 1, surface proteins, live, attenuated, Dengue virus, serotype 2, live, attenuated, Dengue virus, serotype 2, expressing Dengue virus, serotype 3, surface proteins, live, attenuated, Dengue virus, serotype 2, expressing Dengue virus, serotype 4, surface proteins, live, attenuated | Takeda Pharmaceuticals International AG Ireland Branch | — |
| Qdenga powder and solvent for solution for injection EU/1/22/1699/004 |
Dengue virus, serotype 2, expressing Dengue virus, serotype 1, surface proteins, live, attenuated, Dengue virus, serotype 2, live, attenuated, Dengue virus, serotype 2, expressing Dengue virus, serotype 3, surface proteins, live, attenuated, Dengue virus, serotype 2, expressing Dengue virus, serotype 4, surface proteins, live, attenuated | Takeda Pharmaceuticals International AG Ireland Branch | — |
| QINLOCK 50 mg tablets EU/1/21/1569/001-002 |
Ripretinib | Deciphera Pharmaceuticals (Netherlands) B.V. | — |
| Qoyvolma 130 mg concentrate for solution for infusion EU/1/25/1925/003 |
Ustekinumab | Celltrion Healthcare Hungary Kft. | — |
| Qoyvolma 45 mg solution for injection in pre-filled syringe EU/1/25/1925/001 |
Ustekinumab | Celltrion Healthcare Hungary Kft. | — |
| Qoyvolma 90 mg solution for injection in pre-filled syringe EU/1/25/1925/002 |
Ustekinumab | Celltrion Healthcare Hungary Kft. | — |
| Qtern 5 mg/10 mg film-coated tablets EU/1/16/1108/001-004 |
Dapagliflozin, Saxagliptin | AstraZeneca AB | — |
| Quadramet 1.3 GBq/mL solution for injection. EU/1/97/057/001 |
CIS bio International | — | |
| Quinsair 240mg Nebuliser solution EU/1/14/973/001 |
Levofloxacin | Chiesi Farmaceutici S.p.A. | — |
| Quofenix 300 mg powder for concentrate for solution for infusion EU/1/19/1393/001 |
DELAFLOXACIN MEGLUMINE | A. Menarini Industrie Farmaceutische Riunite S.r.l. | — |
| Quofenix 450 mg tablets EU/1/19/1393/002-007 |
DELAFLOXACIN MEGLUMINE | A. Menarini Industrie Farmaceutische Riunite S.r.l. | — |
| Qutenza 179 mg cutaneous patch EU/1/09/524/001-002 |
Capsaicin | Grünenthal GmbH | — |
Priya Life Science (2026). Irish Medicines Database. Available at: https://priyalifescience.com/medicines (Accessed: 16 August 2026).
Data: Health Products Regulatory Authority (HPRA) open dataset (“Authorised or Transfer Pending Products”), licensed CC BY 4.0, refreshed daily. Regulatory information only — not medical advice.